255 related articles for article (PubMed ID: 32516280)
1. Differences in Growth of HIV-exposed Uninfected Infants in Ethiopia According to Timing of In-utero Antiretroviral Therapy Exposure.
Ejigu Y; Magnus JH; Sundby J; Magnus MC
Pediatr Infect Dis J; 2020 Aug; 39(8):730-736. PubMed ID: 32516280
[TBL] [Abstract][Full Text] [Related]
2. Lower birth weight-for-age and length-for-age z-scores in infants with in-utero HIV and ART exposure: a prospective study in Cape Town, South Africa.
Nyemba DC; Kalk E; Madlala HP; Malaba TR; Slogrove AL; Davies MA; Boulle A; Myer L; Powis KM
BMC Pregnancy Childbirth; 2021 May; 21(1):354. PubMed ID: 33947351
[TBL] [Abstract][Full Text] [Related]
3. Growth trajectories of breastfed HIV-exposed uninfected and HIV-unexposed children under conditions of universal maternal antiretroviral therapy: a prospective study.
le Roux SM; Abrams EJ; Donald KA; Brittain K; Phillips TK; Nguyen KK; Zerbe A; Kroon M; Myer L
Lancet Child Adolesc Health; 2019 Apr; 3(4):234-244. PubMed ID: 30773459
[TBL] [Abstract][Full Text] [Related]
4. Growth patterns of infants with in- utero HIV and ARV exposure in Cape Town, South Africa and Lusaka, Zambia.
Nyemba DC; Kalk E; Vinikoor MJ; Madlala HP; Mubiana-Mbewe M; Mzumara M; Moore CB; Slogrove AL; Boulle A; Davies MA; Myer L; Powis K
BMC Public Health; 2022 Jan; 22(1):55. PubMed ID: 35000577
[TBL] [Abstract][Full Text] [Related]
5. Extended Prophylaxis With Nevirapine Does Not Affect Growth in HIV-Exposed Infants.
Onyango-Makumbi C; Owora AH; Mwiru RS; Mwatha A; Young AM; Moodley D; Coovadia HM; Stranix-Chibanda L; Manji K; Maldonado Y; Richardson P; Andrew P; George K; Fawzi W; Fowler MG
J Acquir Immune Defic Syndr; 2019 Dec; 82(4):377-385. PubMed ID: 31567725
[TBL] [Abstract][Full Text] [Related]
6. Maternal breastfeeding and education impact infant growth and development more than in-utero HIV/antiretroviral therapy exposure in context of universal antiretroviral therapy.
Cherkos AS; LaCourse SM; Kinuthia J; Mecha J; Enquobahrie DA; Escudero JN; John-Stewart G
AIDS; 2024 Mar; 38(4):537-546. PubMed ID: 37967230
[TBL] [Abstract][Full Text] [Related]
7. In Utero Exposure to Antiretroviral Drugs: Effect on Birth Weight and Growth Among HIV-exposed Uninfected Children in Brazil.
Hofer CB; Keiser O; Zwahlen M; Lustosa CS; Frota AC; de Oliveira RH; Abreu TF; Carvalho AW; Araujo LE; Egger M
Pediatr Infect Dis J; 2016 Jan; 35(1):71-7. PubMed ID: 26741583
[TBL] [Abstract][Full Text] [Related]
8. Cardiac effects of in-utero exposure to antiretroviral therapy in HIV-uninfected children born to HIV-infected mothers.
Lipshultz SE; Williams PL; Zeldow B; Wilkinson JD; Rich KC; van Dyke RB; Seage GR; Dooley LB; Kaltman JR; Siberry GK; Mofenson LM; Shearer WT; Colan SD;
AIDS; 2015 Jan; 29(1):91-100. PubMed ID: 25562493
[TBL] [Abstract][Full Text] [Related]
9. In-utero exposure to antiretrovirals and neurodevelopment among HIV-exposed-uninfected children in Botswana.
Chaudhury S; Mayondi GK; Williams PL; Leidner J; Shapiro R; Diseko M; Ajibola G; Holding P; Tepper V; Makhema J; Petlo C; Seage GR; Lockman S; Kammerer B
AIDS; 2018 Jun; 32(9):1173-1183. PubMed ID: 29547434
[TBL] [Abstract][Full Text] [Related]
10. Higher prevalence of stunting and poor growth outcomes in HIV-exposed uninfected than HIV-unexposed infants in Kenya.
Neary J; Langat A; Singa B; Kinuthia J; Itindi J; Nyaboe E; Ng'anga' LW; Katana A; John-Stewart GC; McGrath CJ
AIDS; 2022 Mar; 36(4):605-610. PubMed ID: 34750290
[TBL] [Abstract][Full Text] [Related]
11. Growth of HIV-Exposed Uninfected Infants in the First 6 Months of Life in South Africa: The IeDEA-SA Collaboration.
Morden E; Technau KG; Giddy J; Maxwell N; Keiser O; Davies MA
PLoS One; 2016; 11(4):e0151762. PubMed ID: 27049853
[TBL] [Abstract][Full Text] [Related]
12. Initiation of Antiretroviral Therapy Before Pregnancy Reduces the Risk of Infection-related Hospitalization in Human Immunodeficiency Virus-exposed Uninfected Infants Born in a High-income Country.
Goetghebuer T; Smolen KK; Adler C; Das J; McBride T; Smits G; Lecomte S; Haelterman E; Barlow P; Piedra PA; van der Klis F; Kollmann TR; Lauffenburger DA; Alter G; Levy J; Marchant A
Clin Infect Dis; 2019 Mar; 68(7):1193-1203. PubMed ID: 30215689
[TBL] [Abstract][Full Text] [Related]
13. Effects of in utero antiretroviral exposure on longitudinal growth of HIV-exposed uninfected infants in Botswana.
Powis KM; Smeaton L; Ogwu A; Lockman S; Dryden-Peterson S; van Widenfelt E; Leidner J; Makhema J; Essex M; Shapiro RL
J Acquir Immune Defic Syndr; 2011 Feb; 56(2):131-8. PubMed ID: 21124227
[TBL] [Abstract][Full Text] [Related]
14. Increased infectious-cause hospitalization among infants who are HIV-exposed uninfected compared with HIV-unexposed.
Anderson K; Kalk E; Madlala HP; Nyemba DC; Kassanjee R; Jacob N; Slogrove A; Smith M; Eley BS; Cotton MF; Muloiwa R; Spittal G; Kroon M; Boulle A; Myer L; Davies MA
AIDS; 2021 Nov; 35(14):2327-2339. PubMed ID: 34324450
[TBL] [Abstract][Full Text] [Related]
15. In utero antiretroviral exposure and sociodemographic characteristics on neurodevelopment of HIV-exposed uninfected children versus HIV-unexposed uninfected healthy children in Malawi.
Zhang X; Wang L; Han J; Xie L; Wu N; Nyirenda R; Shumba K; Simwanza W; Kulyk O; Chilapondwa V; Li X
Int J Gynaecol Obstet; 2021 Jun; 153(3):424-437. PubMed ID: 33270235
[TBL] [Abstract][Full Text] [Related]
16. Neurodevelopmental and behavioural outcomes of HIV-exposed uninfected and HIV-unexposed children at 2-3 years of age in Cape Town, South Africa.
Springer PE; Slogrove AL; Kidd M; Kalk E; Bettinger JA; Esser MM; Cotton MF; Zunza M; Molteno CD; Kruger M
AIDS Care; 2020 Apr; 32(4):411-419. PubMed ID: 31280587
[TBL] [Abstract][Full Text] [Related]
17. Development assessment of HIV exposed children aged 6-18 months: a cohort study from North India.
Rajan R; Seth A; Mukherjee SB; Chandra J
AIDS Care; 2017 Nov; 29(11):1404-1409. PubMed ID: 28278563
[TBL] [Abstract][Full Text] [Related]
18. Height, weight, and growth in children born to mothers with HIV-1 infection in Europe.
Newell ML; Borja MC; Peckham C;
Pediatrics; 2003 Jan; 111(1):e52-60. PubMed ID: 12509595
[TBL] [Abstract][Full Text] [Related]
19. Maternal Tenofovir Disoproxil Fumarate Use in Pregnancy and Growth Outcomes among HIV-Exposed Uninfected Infants in Kenya.
Pintye J; Langat A; Singa B; Kinuthia J; Odeny B; Katana A; Nganga L; John-Stewart G; McGrath CJ
Infect Dis Obstet Gynecol; 2015; 2015():276851. PubMed ID: 26823647
[TBL] [Abstract][Full Text] [Related]
20. Neurodevelopment and in utero antiretroviral exposure of HIV-exposed uninfected infants.
Williams PL; Marino M; Malee K; Brogly S; Hughes MD; Mofenson LM;
Pediatrics; 2010 Feb; 125(2):e250-60. PubMed ID: 20083530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
